HIGHLIGHTS
- who: Lili Li from the Institute of Systems Medicine, Chinese Academy of Medical Science and Peking Union College, Beijing, China, Nankai University, Tianjin, China have published the Article: Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants, in the Journal: (JOURNAL)
- what: The studies have outlined a strategy to identify and engineer neutralizing antibodies against SARSCoV-2 variants. The authors firstly compared the binding of R3P1-E4, CB6, S309 and REGN10933 mAbs with RBD domains from different SARS-CoV-2_variants including B.1.1.7, B.1.351, P.1 and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.